Phase I Vaccine Trial Shows Promise for Preventing Triple-Negative Breast Cancer

(MedPage Today) — At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA) vaccine designed to help prevent triple-negative breast cancer (TNBC), particularly among women at…

Source link : https://www.medpagetoday.com/meetingcoverage/sabcs-vp-earlybrca/118929

Author :

Publish date : 2025-12-10 15:26:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Phase I Vaccine Trial Shows Promise for Preventing Triple-Negative Breast Cancer

AI Model Improves Prediction of Early and Late Breast Cancer Recurrence

Inside the wild experiments physicists would do with zero limits

Related Posts

Incretin-Based Meds May Modestly Raise Biliary Risk in T2D

RFK Jr. Tops This Year’s Shkreli Awards

Should Congress Intervene in the Newborn Hep B Vaccine Controversy?

Triplet Delays Breast Cancer Progression in First-Line Maintenance Setting

Wes Streeting confirms public inquiry into Teesside NHS trust

Hospitals hit by ‘super flu’ wave with no sign when peak will come

Incretin-Based Meds May Modestly Raise Biliary Risk in T2D

RFK Jr. Tops This Year’s Shkreli Awards

Should Congress Intervene in the Newborn Hep B Vaccine Controversy?

Triplet Delays Breast Cancer Progression in First-Line Maintenance Setting

Wes Streeting confirms public inquiry into Teesside NHS trust

Hospitals hit by ‘super flu’ wave with no sign when peak will come

Flipped-Dose Immunotherapy May Improve Melanoma Outcomes

Flu in four charts – how this year’s winter outbreak is different

Categories

Archives